Ionis Days Of Inventory On Hand from 2010 to 2024

IONS Stock  USD 40.93  1.35  3.19%   
Ionis Pharmaceuticals Days Of Inventory On Hand yearly trend continues to be comparatively stable with very little volatility. Days Of Inventory On Hand is likely to outpace its year average in 2024. From the period from 2010 to 2024, Ionis Pharmaceuticals Days Of Inventory On Hand quarterly data regression had r-value of  0.70 and coefficient of variation of  122.25. View All Fundamentals
 
Days Of Inventory On Hand  
First Reported
2010-12-31
Previous Quarter
1.1 K
Current Value
1.2 K
Quarterly Volatility
641.19542192
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Ionis Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ionis main balance sheet or income statement drivers, such as Depreciation And Amortization of 23.6 M, Interest Expense of 79.4 M or Total Revenue of 827 M, as well as many exotic indicators such as Price To Sales Ratio of 15.6, Dividend Yield of 0.0 or PTB Ratio of 17.8. Ionis financial statements analysis is a perfect complement when working with Ionis Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement Ionis Pharmaceuticals' financial leverage analysis and stock options assessment as well as various Ionis Pharmaceuticals Technical models . Check out the analysis of Ionis Pharmaceuticals Correlation against competitors.
For more information on how to buy Ionis Stock please use our How to Invest in Ionis Pharmaceuticals guide.

Latest Ionis Pharmaceuticals' Days Of Inventory On Hand Growth Pattern

Below is the plot of the Days Of Inventory On Hand of Ionis Pharmaceuticals over the last few years. It is Ionis Pharmaceuticals' Days Of Inventory On Hand historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ionis Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Days Of Inventory On Hand10 Years Trend
Slightly volatile
   Days Of Inventory On Hand   
       Timeline  

Ionis Days Of Inventory On Hand Regression Statistics

Arithmetic Mean524.51
Geometric Mean92.54
Coefficient Of Variation122.25
Mean Deviation547.05
Median15.93
Standard Deviation641.20
Sample Variance411,132
Range1.7K
R-Value0.70
Mean Square Error227,312
R-Squared0.49
Significance0
Slope100.01
Total Sum of Squares5.8M

Ionis Days Of Inventory On Hand History

2024 1192.8
2023 1136.0
2022 574.43
2021 823.11
2020 668.1
2019 1658.93
2018 1721.12

About Ionis Pharmaceuticals Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Ionis Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Ionis Pharmaceuticals investors use historical funamental indicators, such as Ionis Pharmaceuticals's Days Of Inventory On Hand, to determine how well the company is positioned to perform in the future. Although Ionis Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Ionis Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Ionis Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Ionis Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Ionis Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Of Inventory On Hand1.1 K1.2 K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Ionis Pharmaceuticals is a strong investment it is important to analyze Ionis Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ionis Pharmaceuticals' future performance. For an informed investment choice regarding Ionis Stock, refer to the following important reports:
Check out the analysis of Ionis Pharmaceuticals Correlation against competitors.
For more information on how to buy Ionis Stock please use our How to Invest in Ionis Pharmaceuticals guide.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Complementary Tools for Ionis Stock analysis

When running Ionis Pharmaceuticals' price analysis, check to measure Ionis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ionis Pharmaceuticals is operating at the current time. Most of Ionis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ionis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ionis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ionis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Transaction History
View history of all your transactions and understand their impact on performance
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Stocks Directory
Find actively traded stocks across global markets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Is Ionis Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ionis Pharmaceuticals. If investors know Ionis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ionis Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.44)
Earnings Share
(2.56)
Revenue Per Share
5.501
Quarterly Revenue Growth
1.136
Return On Assets
(0.08)
The market value of Ionis Pharmaceuticals is measured differently than its book value, which is the value of Ionis that is recorded on the company's balance sheet. Investors also form their own opinion of Ionis Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Ionis Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ionis Pharmaceuticals' market value can be influenced by many factors that don't directly affect Ionis Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ionis Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ionis Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ionis Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.